Sebastian Cuenca Miranda
Director/Board Member at Spanish Issuers' Association
Profile
Sebastian Cuenca Miranda is currently the Director at the Spanish Issuers' Association since 2006 and a Professor at Universidad CEU San Pablo.
He previously worked as a Secretary at Zeltia SA, Xylazel SA, and Sylentis SA, and as the Secretary & General Counsel at Pharma Mar SA. Mr. Cuenca Miranda completed his undergraduate degree at the Instituto Catolico de Administracion y Direccion de Empresas.
Sebastian Cuenca Miranda active positions
| Companies | Position | Start |
|---|---|---|
| Universidad CEU San Pablo | Corporate Officer/Principal | - |
| Spanish Issuers' Association | Director/Board Member | 2005-12-31 |
Former positions of Sebastian Cuenca Miranda
| Companies | Position | End |
|---|---|---|
| PHARMA MAR, S.A. | General Counsel | 2019-07-28 |
Sylentis SA
 Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Corporate Secretary | - |
Xylazel SA
 Xylazel SA Industrial SpecialtiesProcess Industries Xylazel SA manufactures paints, varnishes and allied products. It specializes in the manufacture of protective products for wood, metal, gardens, paintings and walls. The firm’s products include primers and treatments, outdoor lasurs, antioxidant enamels metal spray accessories, indoor and outdoor paint, universal sprays, powder putty and diluents. The company was founded in 1975 and is headquartered in Pontevedra, Spain. | Corporate Secretary | - |
| ZELTIA SA | Corporate Secretary | - |
Training of Sebastian Cuenca Miranda
| Instituto Catolico de Administracion y Direccion de Empresas | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARMA MAR, S.A. | Health Technology |
| Private companies | 4 |
|---|---|
Zeltia SA
 Zeltia SA BiotechnologyHealth Technology Zeltia SA is a holding company, which develops marine-based drugs in the field of oncology. It operates through the Biopharmaceuticals and Consumer Chemicals segments. The Biopharmaceuticals segment engages in the research and marketing of anti-tumor drugs, diagnosis kits, and development of therapies based on reducing or silencing gene expression. The Consumer Chemicals segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and related products. The company was founded on August 3, 1939 and is headquartered in Madrid, Spain. | Health Technology |
Xylazel SA
Xylazel SA Industrial SpecialtiesProcess Industries Xylazel SA manufactures paints, varnishes and allied products. It specializes in the manufacture of protective products for wood, metal, gardens, paintings and walls. The firm’s products include primers and treatments, outdoor lasurs, antioxidant enamels metal spray accessories, indoor and outdoor paint, universal sprays, powder putty and diluents. The company was founded in 1975 and is headquartered in Pontevedra, Spain. | Process Industries |
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Health Technology |
| Spanish Issuers' Association |
- Stock Market
- Insiders
- Sebastian Cuenca Miranda
